The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, ...

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...

The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with ...

Dr Miriam Stoppard on the news that a drug used to control cholesterol could reduce the risk of debilitating diabetic ...

Scientists have found evidence that a simple two-drug combination could prevent a specific type of recurrent pregnancy loss.

Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...

If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...

World leaders meeting in New York have backed a new set of goals and pledged to find US$100 million in funding to address the problem of drug-resistant bacteria, a global crisis that is all the more ...

Schizophrenia causes persistent delusions and hallucinations and significantly impairs the way patients perceive reality.

SAN DIEGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRNX) today announced the submission of a New Drug Application (NDA) ...

Parents pushed for years for treatments for the neuron disease Niemann-Pick type C. After setbacks, one drug now has FDA ...

Metformin, a common medication used to treat type 2 diabetes, may also help reduce the viral reservoir in people living with ...